![]() |
Volumn 70, Issue 10, 2013, Pages 1331-1332
|
ABO blood groups and risk for progressive multifocal leukoencephalopathy
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIRETROVIRUS AGENT;
NATALIZUMAB;
VIRUS ANTIBODY;
AUTOIMMUNE DISEASE;
B LYMPHOCYTE;
BLOOD GROUP A;
BLOOD GROUP AB;
BLOOD GROUP ABO SYSTEM;
BLOOD GROUP B;
BLOOD GROUP O;
BRAIN CAPILLARY;
BRAIN DAMAGE;
BRAIN METASTASIS;
CELL TYPE;
ERYTHROCYTE AGGREGATION;
GRAY MATTER;
HISTOPATHOLOGY;
HUMAN;
HUMAN CELL;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
HUMAN TISSUE;
JC VIRUS;
LETTER;
MAJOR CLINICAL STUDY;
MICROANGIOPATHY;
NUCLEAR MAGNETIC RESONANCE IMAGING;
OPPORTUNISTIC INFECTION;
PRIORITY JOURNAL;
PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY;
RISK ASSESSMENT;
SURVIVAL RATE;
SURVIVAL TIME;
VIRION;
WHITE MATTER;
|
EID: 84885827011
PISSN: 21686149
EISSN: None
Source Type: Journal
DOI: 10.1001/jamaneurol.2013.3932 Document Type: Letter |
Times cited : (6)
|
References (6)
|